These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9377844)

  • 1. [Felbamate: a long-term study in subjects with refractory epilepsy].
    De Romanis F; Sopranzi N
    Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Felbamate: successful development of a new compound for the treatment of epilepsy.
    Schmidt D
    Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
    Palmer KJ; McTavish D
    Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Felbamate in refractory partial epilepsy.
    Canger R; Vignoli A; Bonardi R; Guidolin L
    Epilepsy Res; 1999 Mar; 34(1):43-8. PubMed ID: 10194111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience.
    Shah YD; Singh K; Friedman D; Devinsky O; Kothare SV
    Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of felbamate in therapy for partial epilepsy in children.
    Carmant L; Holmes GL; Sawyer S; Rifai N; Anderson J; Mikati MA
    J Pediatr; 1994 Sep; 125(3):481-6. PubMed ID: 8071763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
    Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
    Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
    Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felbamate monotherapy for partial-onset seizures: an active-control trial.
    Faught E; Sachdeo RC; Remler MP; Chayasirisobhon S; Iragui-Madoz VJ; Ramsay RE; Sutula TP; Kanner A; Harner RN; Kuzniecky R
    Neurology; 1993 Apr; 43(4):688-92. PubMed ID: 8469323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felbamate.
    Pellock JM
    Epilepsia; 1999; 40 Suppl 5():S57-62. PubMed ID: 10530695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Felbamate.
    Leppik IE
    Epilepsia; 1995; 36 Suppl 2():S66-72. PubMed ID: 8784215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term use of felbamate in children with severe refractory epilepsy.
    Cilio MR; Kartashov AI; Vigevano F
    Epilepsy Res; 2001 Nov; 47(1-2):1-7. PubMed ID: 11673015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Felbamate in the treatment of refractory partial-onset seizures.
    Jensen PK
    Epilepsia; 1993; 34 Suppl 7():S25-9. PubMed ID: 8243375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Felbamate as an add-on therapy for refractory epilepsy.
    Shi LL; Dong J; Ni H; Geng J; Wu T
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008295. PubMed ID: 21249704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Felbamate in the treatment of Lennox-Gastaut syndrome.
    Jensen PK
    Epilepsia; 1994; 35 Suppl 5():S54-7. PubMed ID: 8039473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felbamate monotherapy has stimulant-like effects in patients with epilepsy.
    Ketter TA; Malow BA; Flamini R; Ko D; White SR; Post RM; Theodore WH
    Epilepsy Res; 1996 Mar; 23(2):129-37. PubMed ID: 8964274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rise and fall of felbamate as a treatment for partial epilepsy--aplastic anemia and hepatic failure to blame?
    Thakkar K; Billa G; Rane J; Chudasama H; Goswami S; Shah R
    Expert Rev Neurother; 2015; 15(12):1373-5. PubMed ID: 26566191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felbamate pharmacology and use in epilepsy.
    Burdette DE; Sackellares JC
    Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felbamate monotherapy: controlled trial in patients with partial onset seizures.
    Sachdeo R; Kramer LD; Rosenberg A; Sachdeo S
    Ann Neurol; 1992 Sep; 32(3):386-92. PubMed ID: 1416808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Felbamate in an adult population with severe refractory epilepsy.
    Kearney H; Delanty N
    Ir Med J; 2009; 102(10):326-8. PubMed ID: 20108801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.